# Ryser, Mark R., D.M.D. – FDA Inspection, Sep 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/ryser-mark-r-dmd/bfce9da1-8d91-4435-8484-ec055d3ef14a
Source feed: FDA_Inspections

> FDA inspection 1066009 of Ryser, Mark R., D.M.D., September 18, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1066009
- Company Name: Ryser, Mark R., D.M.D.
- Inspection Date: 2018-09-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dawn-c-olenjack/b5a18d10-cd4b-405e-9016-8f5274a33000)
- [Company Rep](https://www.keypedia.com/people/stephen-t-hansen/7ae1f1df-7f68-4264-bd87-ea21c8d879bb)
- [Issuing Officer](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)

Company: https://www.keypedia.com/companies/ryser-mark-r-dmd/a536b793-657b-4ea2-aaa8-7e40831e77b6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c